Medicago announces two presentations at the 2008 AAPS National Biotechnology Conference

QUEBEC CITY, June 23 /CNW/ - Medicago Inc. (TSX-V:MDG) (the "Company"), today announced that it will be presenting an overview of its development of vaccines generated from plant-made Virus-Like Particles and unique technology platform at the 2008 American Association of Pharmaceutical Scientists (AAPS) National Biotechnology Conference, from June 22-25, 2008, at the Metro Convention Centre in Toronto, Ontario. Dr. Louis Vezina, Medicago's Chief Scientific Officer will give a presentation on "How to Produce Therapeutic Vaccines in Plants" in a Plenary Session entitled "Pharmaceutical Biotechnology - the Next Steps", today at 8:30 am EDT. Ms. Irene Clement, Acting Vice President Regulatory Affairs will give a presentation on "Production and Characterization of Plant-based Vaccines and Therapeutic Antibodies" in a Session entitled "Plant-based Biologicals: Developmental and Regulatory Aspects" today at 1:00 pm EDT.